Grants and Contributions

The Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund aims to improve pandemic readiness and sector growth by strengthening research and talent capacity in Canada and contributing to and leveraging collaborations across the entire biomanufacturing ecosystem and various sectors.

The Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund aims to improve pandemic readiness and sector growth by strengthening research and talent capacity in Canada and contributing to and leveraging collaborations across the entire biomanufacturing ecosystem and various sectors.

The Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund aims to improve pandemic readiness and sector growth by strengthening research and talent capacity in Canada and contributing to and leveraging collaborations across the entire biomanufacturing ecosystem and various sectors.

The Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund aims to improve pandemic readiness and sector growth by strengthening research and talent capacity in Canada and contributing to and leveraging collaborations across the entire biomanufacturing ecosystem and various sectors.

Project activities include: (1) strengthening epidemiological surveillance; (2) supporting early and appropriate case management; (3) training health community workers; and (4) providing medical supplies and vaccinations as appropriate.

NRC provides contribution funding for the maintenance and operation of the BMC facility in a constant Good Manufacturing Practice (GMP)-readiness state to respond to pandemic and other health emergencies, ensuring surety of domestic vaccines and other biologics for Canadians.

This Project aims to reduce the incidence of COVID-19 related death and serious illness, particularly amongst priority groups and vulnerable populations, by increasing equitable access to and uptake of COVID-19 vaccines in five countries in the African region. The Project will support health systems strengthening to enable the delivery of gender-equitable COVID-19 vaccination and routine health services.

The tomato brown rugose fruit virus (ToBRFV) is an emerging disease threatening tomato industry by deteriorating fruit quality, reducing shelf life and making fruits unmarketable from 30% to 70%. ToBRFV can overcome all known genetic resistance genes resulting in all commercial tomato varieties being susceptible to the virus. Efforts to manage ToBRFV currently focus on using certified seed and maintaining strict biosecurity and sanitation practices. We have developed some attenuated ToBRFV strains that will be tested for the efficacy to protect tomato plants from the infection of wild-type ToBRFV in a commercial greenhouse.

The tomato brown rugose fruit virus (ToBRFV) is an emerging disease threatening tomato industry by deteriorating fruit quality, reducing shelf life and making fruits unmarketable from 30% to 70%. ToBRFV can overcome all known genetic resistance genes resulting in all commercial tomato varieties being susceptible to the virus. Efforts to manage ToBRFV currently focus on using certified seed and maintaining strict biosecurity and sanitation practices. We have developed some attenuated ToBRFV strains that will be tested for the efficacy to protect tomato plants from the infection of wild-type ToBRFV in a commercial greenhouse.

Examples of livelihood-based anticipatory actions for agriculture include: (1) rehabilitating water harvesting systems and reinforcing river banks; (2) distributing conditional or unconditional cash transfers, crop varieties, animal feed and supplements; (3) protecting livestock including vaccination, animal health campaigns and evacuation; and (4) diversifying livelihood.